Context Capital Management »

Sarepta Therapeutics shares owned by Context Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Context Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $9.6M 8.0k 1202.13
2022-12-31 $6.4M 5.5k 1157.45
2022-09-30 $10M 10k 1029.50

More positions owned by Context Capital Management

Echostar Corp Note 3.875%11/3
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Peloton Interactive Note 5.500%12/0 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
Equinox Gold Corp Note 4.750%10/1 (Principal)
Pacira Biosciences Note 2.125% 5/1 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Groupon Note 4.875% 6/3 (Principal)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Immunocore Hldgs Note 2.500% 2/0 (Principal)
Century Alum Note 2.750% 5/0 (Principal)
Strategy Note 0.875% 3/1 (Principal)
Rivian Automotive Note 4.625% 3/1 (Principal)

View all positions for Context Capital Management